Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Metzger Michael A
Pyxis Oncology | 3: Initial statement of beneficial ownership of securities-Director Metzger Michael A
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh
Pyxis Oncology | 10-Q: Q1 2024 Earnings Report
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 14, 2024
Pyxis Oncology | ARS: Annual Report to Security Holders
Pyxis Oncology | DEFA14A: Others
Pyxis Oncology | DEF 14A: Definitive information statements
Pyxis Oncology | 424B2: Prospectus
Pyxis Oncology | EFFECT: Others
Pyxis Oncology | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lara Sullivan(8.89%)
Pyxis Oncology | CORRESP: CORRESP
Pyxis Oncology | UPLOAD: Others
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Lara
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director FLAVIN JOHN L
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Civik Thomas
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director HUMPHREY RACHEL
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Connealy Pamela Ann
No Data